256 related articles for article (PubMed ID: 32303824)
1. Tacrolimus (FK506) ointment combined with Nb-UVB could activate both hair follicle (HF) and dermal melanocyte precursors in vitiligo: the first histopathological and clinical study.
Gauthier Y; Almasi-Nasrabadi M; Cario-André M; Pain C; Rakhshan A; Ghalamkarpour F
Arch Dermatol Res; 2021 Jul; 313(5):383-388. PubMed ID: 32303824
[TBL] [Abstract][Full Text] [Related]
2. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
[TBL] [Abstract][Full Text] [Related]
3. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
[TBL] [Abstract][Full Text] [Related]
4. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
5. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
6. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
Li R; Qiao M; Wang X; Zhao X; Sun Q
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
[TBL] [Abstract][Full Text] [Related]
7. The effects of NB-UVB on the hair follicle-derived neural crest stem cells differentiating into melanocyte lineage in vitro.
Dong D; Jiang M; Xu X; Guan M; Wu J; Chen Q; Xiang L
J Dermatol Sci; 2012 Apr; 66(1):20-8. PubMed ID: 22391242
[TBL] [Abstract][Full Text] [Related]
8. Vitiligo, NB-UVB and tacrolimus: our experience in Naples.
Baldo A; Lodi G; Di Caterino P; Monfrecola G
G Ital Dermatol Venereol; 2014 Feb; 149(1):123-30. PubMed ID: 24566573
[TBL] [Abstract][Full Text] [Related]
9. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
Majid I
Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
[TBL] [Abstract][Full Text] [Related]
10. Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling.
Goldstein NB; Steel A; Barbulescu CC; Koster MI; Wright MJ; Jones KL; Gao B; Ward B; Woessner B; Trottier Z; Pakieser J; Hu J; Lambert KA; Shellman YG; Fujita M; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2021 Mar; 141(3):638-647.e13. PubMed ID: 32800877
[TBL] [Abstract][Full Text] [Related]
11. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
Fai D; Cassano N; Vena GA
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
13. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study.
Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y
Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595
[TBL] [Abstract][Full Text] [Related]
14. Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial.
Khullar G; Kanwar AJ; Singh S; Parsad D
J Eur Acad Dermatol Venereol; 2015 May; 29(5):925-32. PubMed ID: 25220387
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of using fractional CO
Ghasemloo S; Gauthier Y; Ghalamkarpour F
J Dermatolog Treat; 2019 Nov; 30(7):697-700. PubMed ID: 30592235
[No Abstract] [Full Text] [Related]
16. A comparative study on the use of fractional CO
Bakr RM; Abdel-Gaber RM; Tawfik YM
Dermatol Ther; 2021 Jan; 34(1):e14604. PubMed ID: 33249712
[TBL] [Abstract][Full Text] [Related]
17. Microdermabrasion and topical tacrolimus: A novel combination therapy of vitiligo.
Abd-Elazim NE; Yassa HA; Mahran AM
J Cosmet Dermatol; 2020 Jun; 19(6):1447-1455. PubMed ID: 31668003
[TBL] [Abstract][Full Text] [Related]
18. Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study.
Khemis A; Fontas E; Moulin S; Montaudié H; Lacour JP; Passeron T
J Invest Dermatol; 2020 Aug; 140(8):1533-1537.e2. PubMed ID: 32004567
[TBL] [Abstract][Full Text] [Related]
19. Skin pigmentation and its control: From ultraviolet radiation to stem cells.
Yardman-Frank JM; Fisher DE
Exp Dermatol; 2021 Apr; 30(4):560-571. PubMed ID: 33320376
[TBL] [Abstract][Full Text] [Related]
20. Duration of response in vitiligo lesions after narrowband UVB phototherapy combined with tacrolimus ointment.
Fai D; Fai C; Cassano N; Vena GA
G Ital Dermatol Venereol; 2017 Aug; 152(4):402-404. PubMed ID: 28621124
[No Abstract] [Full Text] [Related]
[Next] [New Search]